Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Metabolic effects of aloe vera gel complex in obese prediabetes and early non-treated diabetic patients: randomized controlled trial.

Choi HC, Kim SJ, Son KY, Oh BJ, Cho BL.

Nutrition. 2013 Sep;29(9):1110-4. doi: 10.1016/j.nut.2013.02.015. Epub 2013 Jun 2.

PMID:
23735317
2.

Effects of Aloe vera supplementation in subjects with prediabetes/metabolic syndrome.

Devaraj S, Yimam M, Brownell LA, Jialal I, Singh S, Jia Q.

Metab Syndr Relat Disord. 2013 Feb;11(1):35-40. doi: 10.1089/met.2012.0066. Epub 2012 Oct 4.

PMID:
23035844
3.

A meal replacement regimen improves blood glucose levels in prediabetic healthy individuals with impaired fasting glucose.

König D, Kookhan S, Schaffner D, Deibert P, Berg A.

Nutrition. 2014 Nov-Dec;30(11-12):1306-9. doi: 10.1016/j.nut.2014.03.014. Epub 2014 Mar 31.

PMID:
25194963
6.

[Expression of omentin in adipose tissues in obese and type 2 diabetic patients].

Cai RC, Wei L, DI JZ, Yu HY, Bao YQ, Jia WP.

Zhonghua Yi Xue Za Zhi. 2009 Feb 17;89(6):381-4. Chinese.

PMID:
19567114
7.

Effect of a polyphenol-rich extract from Aloe vera gel on experimentally induced insulin resistance in mice.

Pérez YY, Jiménez-Ferrer E, Zamilpa A, Hernández-Valencia M, Alarcón-Aguilar FJ, Tortoriello J, Román-Ramos R.

Am J Chin Med. 2007;35(6):1037-46.

PMID:
18186589
9.
10.

Effect of dexamethasone on glucose homeostasis in normal and prediabetic subjects with a first-degree relative with type 2 diabetes mellitus.

Taheri N, Aminorroaya A, Ismail-Beigi F, Amini M.

Endocr Pract. 2012 Nov-Dec;18(6):855-63. doi: 10.4158/EP12057.OR.

PMID:
22784841
11.

Reduction of Fasting Blood Glucose and Hemoglobin A1c Using Oral Aloe Vera: A Meta-Analysis.

Dick WR, Fletcher EA, Shah SA.

J Altern Complement Med. 2016 Jun;22(6):450-7. doi: 10.1089/acm.2015.0122. Epub 2016 May 6.

PMID:
27152917
12.

Dietary Aloe QDM Complex Reduces Obesity-Induced Insulin Resistance and Adipogenesis in Obese Mice Fed a High-Fat Diet.

Shin S, Kim S, Oh HE, Kong H, Shin E, Do SG, Jo TH, Park YI, Lee CK, Kim K.

Immune Netw. 2012 Jun;12(3):96-103. doi: 10.4110/in.2012.12.3.96. Epub 2012 Jun 30.

14.

Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.

Vogeser M, König D, Frey I, Predel HG, Parhofer KG, Berg A.

Clin Biochem. 2007 Sep;40(13-14):964-8. Epub 2007 Jun 2.

PMID:
17583689
15.
16.

Reduction of insulin resistance and plasma glucose level by salsalate treatment in persons with prediabetes.

Faghihimani E, Aminorroaya A, Rezvanian H, Adibi P, Ismail-Beigi F, Amini M.

Endocr Pract. 2012 Nov-Dec;18(6):826-33. doi: 10.4158/EP12064.OR.

PMID:
22784842
17.

Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.

Kelley DE, Bray GA, Pi-Sunyer FX, Klein S, Hill J, Miles J, Hollander P.

Diabetes Care. 2002 Jun;25(6):1033-41. Erratum in: Diabetes Care. 2003 Mar;26(3):971..

PMID:
12032111
18.

Bromocriptine: a novel approach to the treatment of type 2 diabetes.

Pijl H, Ohashi S, Matsuda M, Miyazaki Y, Mahankali A, Kumar V, Pipek R, Iozzo P, Lancaster JL, Cincotta AH, DeFronzo RA.

Diabetes Care. 2000 Aug;23(8):1154-61.

19.

Effect of Aloe vera on glycaemic control in prediabetes and type 2 diabetes: a systematic review and meta-analysis.

Suksomboon N, Poolsup N, Punthanitisarn S.

J Clin Pharm Ther. 2016 Apr;41(2):180-8. doi: 10.1111/jcpt.12382. Epub 2016 Mar 23. Review.

PMID:
27009750
20.

Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes.

Derosa G, Cicero AF, D'Angelo A, Fogari E, Maffioli P.

J Clin Pharm Ther. 2012 Apr;37(2):187-95. doi: 10.1111/j.1365-2710.2011.01280.x. Epub 2011 Aug 4.

PMID:
21812797

Supplemental Content

Support Center